8 Results

People

  1. Sauter
    Sauter
  2. Brentjens
    Brentjens
  3. Curran
    Curran
  4. Park
    Park
  5. Riviere
    Riviere
  6. Sadelain
    Sadelain
  7. Wang
    Wang
  8. Bernal
    Bernal
  9. Halton
    Halton
  10. Purdon
    Purdon

Groups

  1. Center for Hematologic Malignancies (8)
  2. Department of Medicine (8)
  3. GSK Faculty (8)
  4. Hematologic Malignancies Research (8)
  5. Hematologic Malignancies, Division of (8)
  6. Nursing (8)
  7. Bone Marrow Transplant (7)
  8. Adult Leukemia (6)
  9. Sloan Kettering Institute Faculty (6)
  10. Advanced Practice Providers (5)
  1. "Hematologic Malignancies Research"
  2. "Center for Hematologic Malignancies"
  3. "2015"
  4. "Nursing"
Formats
  1. Meeting Abstract (8)
Groups
  1. Center for Hematologic Malignancies (8)
  2. Department of Medicine (8)
  3. GSK Faculty (8)
  4. Hematologic Malignancies Research (8)
  5. Hematologic Malignancies, Division of (8)
  6. Nursing (8)

More Groups

People
  1. Craig Sauter (7)
  2. Isabelle Riviere (5)
  3. Jae Park (5)
  4. Kevin Curran (5)
  5. Michel Sadelain (5)
  6. Renier Brentjens (5)

More People

Years
  1. 2015 (8)
Publications
  1. Blood (5)
  2. Haematologica (1)
  3. Journal of Clinical Oncology (1)
  4. Molecular Therapy (1)
Publishers
  1. American Society of Hematology (5)
  2. American Society of Clinical Oncology (1)
  3. Ferrata Storti Foundation (1)
  4. Nature Publishing Group (1)

Results (8)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Multi-center clinical trial of CAR T cells in pediatric/young adult patients with relapsed B-cell ALL
    Meeting Abstract

    Curran, K. J.; Riviere, I.; Silverman, L. B.; Kobos, R.; Shukla, N.; Steinherz, P. G.; Boulad, F.; Prockop, S.; Scaradavou, A.; Margossian, S. P.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Low dose unfractionated heparin (UFH) prophylaxis is a safe strategy for the prevention of hepatic sinusoidal obstruction syndrome (SOS) in adult allogeneic stem cell transplant (HSCT) recipients
    Meeting Abstract

    Bhatt, V.; Palazzo, M.; Kilroy, K.; Hilden, P.; Maloy, M.; Barker, J. N.; Castro-Malaspina, H. R.; Chung, D. J.; Dahi, P. B.; Hsu, K. C.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Defining the incidence and clinical impact of genomic alterations across different histologic types of lymphoma using a clinically validated comprehensive targeted sequencing assay
    Meeting Abstract

    Batlevi, C.; Rapaport, F.; Intlekofer, A. M.; Reiner, A.; Moskowitz, C. H.; Horwitz, S. M.; Zelenetz, A. D.; Palomba, L.; Moskowitz, A. J.; Gerecitano, J. F.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Distinctive genomic alterations in testicular diffuse large B cell lymphoma
    Meeting Abstract

    Batlevi, C.; Rapaport, F.; Wang, L.; Intlekofer, A. M.; Copeland, A. R.; Jungbluth, A. A.; Reiner, A.; Pichardo, J. D.; Gallagher, M.; Bouvier, N.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Implications of minimal residual disease negative complete remission (MRD-CR) and allogeneic stem cell transplant on safety and clinical outcome of CD19 targeted 19-28z CAR modified T cells in adult patients with relapsed, refractory B-cell ALL
    Meeting Abstract

    Park, J. H.; Riviere, I.; Wang, X. Y.; Bernal, Y.; Purdon, T.; Halton, E.; Wang, Y.; Curran, K. J.; Sauter, C. S.; Sadelain, M.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Efficacy and safety of CD19-targeted 19-28z CAR modified T cells in adult patients with relapsed or refractory B-ALL
    Meeting Abstract

    Park, J.; Riviere, I.; Wang, X.; Bernal, Y.; Purdon, T.; Halton, E.; Curran, K.; Sauter, C.; Sadelain, M.; Brentjens, R.
    Haematologica (2015)

    Fulltext@MSK | Save
  • Phase I clinical trial of autologous CD19-targeted 19-28z CAR T cells in adult patients with Relapsed or refractory B-ALL
    Meeting Abstract

    Park, J. H.; Riviere, I.; Wang, X. Y.; Bernal, Y.; Halton, E.; Quintanilla, H.; Curran, K.; Sauter, C.; Sadelain, M.; Brentjens, R. J.
    Molecular Therapy (2015)

    Fulltext@MSK | Save
  • Efficacy and safety of CD19-targeted 19-28z CAR modified T cells in adult patients with relapsed or refractory B-ALL
    Meeting Abstract

    Park, J. H.; Riviere, I.; Wang, X. Y.; Bernal, Y.; Purdon, T.; Halton, E.; Curran, K. J.; Sauter, C. S.; Sadelain, M.; Brentjens, R. J.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save